Market Cap

Renalytix AI plc Market Capitalization:

£16.5 Million

GBP as of Jan. 1, 2024

US$21.0 Million

business Renalytix AI plc Company Profile

Renalytix AI plc Main Stock Listing

LSE: RENX

Market Capitalization History of Renalytix AI plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $204.45 B
Danaher $177.21 B
Siemens Healthineers AG $63.84 B
DexCom, Inc. $45.21 B
Lonza Group Ltd $39.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Renalytix AI plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £16.5 M -77.98%
Jan. 1, 2023 £74.9 M -79.17%
Jan. 1, 2022 £359.5 M -48.66%
Jan. 1, 2021 £700.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Renalytix AI plc Categories

United Kingdom languages Healthcare languages Diagnostics & Research
United Kingdom Healthcare United Kingdom Diagnostics & Research

Stocks & Indices

Renalytix AI plc has the following listings and related stock indices.


Stock: LSE: RENX

Stock: NASDAQ: RNLX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.